Airing Announces MIT's Dr. Michael J. Cima Joins Technical Advisory Board

Share Article

Micro-CPAP device that generated more than $1 million on Indiegogo aims to improve sleep apnea treatment by developing of first-of-its-kind prototype

News Image
"Airing is innovating to address the most important issue from the patient perspective in CPAP therapy: patient comfort."

Stephen Marsh, President of Airing, today announced that Dr. Michael J. Cima has joined the company’s Technical Advisory Board. Dr. Cima brings a wide range of scientific and entrepreneurial experience that will enhance Airing’s effort to develop a micro-CPAP device, a revolutionary alternative to treat sleep apnea.

Dr. Cima is a Professor of Materials Science and Engineering at the Massachusetts Institute of Technology and has an appointment at the David H. Koch Institute for Integrative Cancer Research. A graduate of the University of California, Berkeley (B.S. and PhD), he joined the MIT faculty in 1986 and became a full Professor in 1995. He was elected to the National Academy of Engineering in 2011 and now holds the David H. Koch Chair of Engineering at MIT.

Professor Cima is author or co-author of more than 250 peer reviewed scientific publications, 50 US patents, and is a recognized expert in the field of materials processing. He is a co-inventor of MIT’s three dimensional printing process. Among other things, he and his collaborators are developing implantable MEMS devices for unprecedented control in the delivery of pharmaceuticals and implantable diagnostic systems.

Professor Cima is author or co-author of more than 250 peer reviewed scientific publications, more than 50 US patents, and is a recognized expert in the field of materials processing. He is a co-inventor of MIT’s three dimensional printing process. He and his collaborators develop technologies for single compartment drug delivery, implanted microelectronics, nanotechnology for diagnostics, and high throughput technology for discovery. Professor Cima also has an extensive entrepreneurial background. He is the co-founder of MicroChips Inc., a developer of microelectronic based drug delivery and diagnostic systems. He helped start Transform Pharmaceuticals, which was ultimately acquired by Johnson and Johnson Corporation. Professor Cima is also a co-founder and director at T2 Biosystems, a medical diagnostics company, and Taris Biomedical, a urology products company.

Professor Cima also has an extensive entrepreneurial background. He is the co-founder of MicroChips Inc., a developer of microelectronic based drug delivery and diagnostic systems. He helped start Transform Pharmaceuticals, which was ultimately acquired by Johnson and Johnson Corporation. Professor Cima is also a co-founder and director at T2 Biosystems, a medical diagnostics company. Most recently, he co-founded SpringLeaf Therapeutics, a specialty pharmaceutical company, and Taris Biomedical, a urology products company.

“We are fortunate to have Dr. Cima join Airing. He is a valuable resource who adds another exciting dimension to our team of scientists and engineers. We are pleased that he has agreed to join us and look forward to his participation in our effort to develop this breakthrough technology for sleep apnea." said Airing’s President Stephen Marsh.

“I get excited about working on important clinical problems where patients benefit. Airing is innovating to address the most important issue from the patient perspective in CPAP therapy: patient comfort,” shared Professor Cima.

For more information, visit http://www.fundairing.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tara G. Frier
Airing
+1 (508) 404-1745
Email >

Margrette Mondillo
Visit website